JP Patent

JP5683261B2 — 癌の予防乃至治療に好適な二本鎖核酸分子、癌細胞増殖抑制剤、並びに医薬

Assigned to KABUSHIKIKAISHA RNAI · Expires 2015-03-11 · 11y expired

What this patent protects

Patent listed against rucaparib-camsylate.

Drugs covered by this patent

rucaparib-camsylate (RUCAPARIB CAMSYLATE)

Patent Metadata

Patent number: JP5683261B2
Jurisdiction: JP
Classification: —
Expires: 2015-03-11
Drug substance claim: No
Drug product claim: No
Assignee: KABUSHIKIKAISHA RNAI
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.